GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Rohto Pharmaceutical Co Ltd (TSE:4527) » Definitions » Accounts Receivable

Rohto Pharmaceutical Co (TSE:4527) Accounts Receivable : 円49,622 Mil (As of Dec. 2023)


View and export this data going back to 1962. Start your Free Trial

What is Rohto Pharmaceutical Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Rohto Pharmaceutical Co's accounts receivables for the quarter that ended in Dec. 2023 was 円49,622 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Rohto Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 61.78.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Rohto Pharmaceutical Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was 円180.67.


Rohto Pharmaceutical Co Accounts Receivable Historical Data

The historical data trend for Rohto Pharmaceutical Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rohto Pharmaceutical Co Accounts Receivable Chart

Rohto Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32,900.00 31,207.00 33,310.00 39,686.00 44,744.00

Rohto Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39,686.00 39,455.00 45,177.00 49,622.00 44,744.00

Rohto Pharmaceutical Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Rohto Pharmaceutical Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Rohto Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=49622/73294*91
=61.78

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Rohto Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Rohto Pharmaceutical Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(81877+0.75 * 49622+0.5 * 48496-96150
-0-5973)/228.139
=180.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Rohto Pharmaceutical Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Rohto Pharmaceutical Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Rohto Pharmaceutical Co (TSE:4527) Business Description

Traded in Other Exchanges
Address
1-8-1, Tatsumi-nishi, Ikuno-ku, Osaka, JPN, 544-8666
Rohto Pharmaceutical Co Ltd is a Japan-based manufacturer and marketer of pharmaceutical products, cosmetics, and functional foods. It undertakes manufacture and sales activities mainly in the health and beauty care categories. The company comprises the four geographical reportable segments of Japan, America, Europe, and Asia. In each segment, it manufactures and sales eye care products including eye drops and eyewash preparations, skincare products including dermal medicines, lip balm, sunscreens, and functional cosmetics, among others, internal medicines and food products including gastrointestinal medicines, traditional Chinese herbal medicines and supplements, and other products and services, such as in-vitro test kits.

Rohto Pharmaceutical Co (TSE:4527) Headlines

No Headlines